Results 61 to 70 of about 74,710 (274)

Safety and pharmacokinetics of inhaled aloxistatin: A first‐in‐human phase 1 dose escalation trial

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Aloxistatin (E64d) is a membrane‐permeable cysteine protease inhibitor prodrug that is converted by esterases to the active metabolite E64c (loxistatin). This first‐in‐human study evaluated the safety, tolerability and pharmacokinetics of single ascending doses of inhaled E64d in healthy volunteers.
Sebastian Fähndrich   +24 more
wiley   +1 more source

Atypical polypoid adenomyoma with extensive morular metaplasia - Case report [PDF]

open access: yes, 2017
Atypical polypoid adenomyoma (APA) is a rare and benign endometrial polypoid lesion. APA was found in a 38-year-old woman who presented with excessive vaginal bleeding.
Maddali, Madhavi   +4 more
core  

Eagle's Syndrome Presenting With Peripheral Facial Palsy—A Case Report

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Eagle's syndrome is a condition caused by an elongated styloid process and is characterized by various symptoms such as cervicofacial pain, foreign body sensation, headache, odynophagia, and otalgia. However, the occurrence of a unilateral peripheral facial palsy as a symptom of Eagle's syndrome has been described only rarely ...
Vincent Holtmann   +3 more
wiley   +1 more source

Long-Term Effects of Helicobacter pylori Eradication on Metachronous Gastric Cancer Development

open access: yesGut and Liver, 2018
Background/AimsGastric mucosal atrophy and intestinal metaplasia due to Helicobacter pylori infection are the main precursor lesions of gastric cancer. The aim of this study was to evaluate the long-term effects of H.
Seung Jun Han   +8 more
doaj   +1 more source

The Serotonergic and Cholinergic Signaling Pathways Drive Gastric Precancerous Lesions and Its Potential Mechanism [PDF]

open access: yesCancer Sci
Vagal cholinergic neurons promote gastric 5‐HT secretion, which drives gastric precancerous lesions through 5‐HTR1D and TRPV4, highlighting these as candidate targets for early intervention. ABSTRACT Gastric cancer (GC) is a leading lethal malignancy globally. Gastric precancerous lesion (GPL) represents a critical step in GC, but its neural regulatory
Gao S   +8 more
europepmc   +2 more sources

Osseous metaplasia in the breast

open access: yes, 2003
Osseous metaplasia in the breast is rare. A clinical and pathological overview of a case of pure osseous metaplasia that was mammographically detected and was not associated with any neoplasm is presented ...
Brem, R. F.   +5 more
core   +1 more source

Endometrial osseous metaplasia in a case of abnormal uterine bleeding [PDF]

open access: yes, 2019
Endometrial osseous metaplasia is an uncommon pathology with varied clinical symptoms. Its pathogenesis is not exactly known and has a benign course. Here we present a case of a 42-year-old female with abnormal uterine bleeding who did not respond to ...
Goswami, Alaka   +3 more
core   +1 more source

Gene signatures characterizing driver mutations in lung squamous carcinoma are predictive of the progression of pre‐cancer lesions

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Lung squamous cell carcinoma (LUSC) is more aggressive than lung adenocarcinoma, and is most often diagnosed at an advanced stage. Here, the authors evaluated gene expression data from LUSC tumors and came up with gene signatures for 34 genetic abnormalities whose expression changes throughout different precancerous stages. Several of these
Yupei Lin   +9 more
wiley   +1 more source

Myeloid metaplasia of the breast

open access: yesAnnals of Oncology, 2001
Hereby, we present the case of a 50-year-old woman with 5-year history of chronic idiopathic myelofibrosis who was referred to our institution after she had noted a lump in the breast. Histological examination of the lesion removed from her left breast yielded the diagnosis of extramedullary hematopoiesis in the breast.
T, Cufer, M, Bracko
openaire   +2 more sources

ATP Citrate Lyase in Metabolic Disease: Mechanistic Insights and Clinical Potential

open access: yesiNew Medicine, EarlyView.
ATP citrate lyase (ACLY) is a central metabolic hub that diverts mitochondrial citrate to fuel de novo lipogenesis, cholesterol biosynthesis, and protein acetylation. Given its robust correlation with pathological changes in multiple human diseases, ACLY inhibitors featuring distinct pharmacological strengths have been developed for therapeutic ...
Wenbiao Wang   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy